Breast Cancer in Women Younger than 40(April 2014)
Breast Cancer Disparities(March 2014)
Preventive Surgery for Women at High Risk of Breast Cancer: The "Angelina Jolie" Effect(February 2014)
Living with metastatic breast cancer(January 2014)
Progress in treating HER2/neu-positive breast cancers(December 2013)
Looking for Clarity: Medical Imaging, Night Shift Work and Breast Cancer Risk(November 2013)
Weighing the Evidence: The Importance of Exercise and Healthy Weight for Breast Cancer Survivors (August 2013)
What happens next- Follow-up care for breast cancer survivors(July 2013)
Breast cancer – a rare, but possible diagnosis for men(June 2013)
Some Questions, Some Answers: Birth Control Pills, Fertility Drugs and Breast Cancer Risk(April 2013)
Is Ductal Carcinoma In Situ (DCIS) Breast Cancer?(March 2013)
Understanding lymphedema (January 2013)
Tumor profiling – personalizing treatment for breast cancer (December 2012)
Latest Research Findings from the 2012 San Antonio Breast Cancer Symposium(December 2012)
Clearing the Air: Does Smoking Increase Breast Cancer Risk?(October 2012)
New Hormone Testing Guideline Will Lead to Better Care for Breast Cancer Patients (April 2010)
Do plastics, body care products or deodorant play a role in breast cancer risk? (April 2010)
The promise of bisphosphonates for breast cancer patients (March 2010)
The role of soy on breast cancer risk and survival (February 2010)
On Mammography - More Agreement than Disagreement (December 2009)
U.S. Preventive Services Task Force (USPSTF) Recommendations on Breast Screening (November 2009)
New Approaches for Breast Irradiation (November 2009)
Comments on Mammography Leading to Over-Diagnosis and Over-Treatment (October 2009)
Update on HER2 Positive Breast Cancer (July 2009)
PARP Inhibitors (June 2009)
Triple Negative Breast Cancer (February 2009)
Eric Winer, M.D., chief scientific advisor, Susan G. Komen for the Cure, talks about the $60 million to be invested in 2009 for breast cancer research.
Watch the Video
Dr. Winer talks about the different types of research to be funded in 2009.
Dr. Winer explains what Komen for the Cure Promise Grants are designed to do.
Dr. Winer discusses how Komen is still successfully able to invest million in research despite the current recession.